Acasti Pharma Inc.

(ACST) Trade

By |

Profile

Acasti Pharma Inc is a biopharmaceutical company operating in Canada. It focuses on the research, development, and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. The key product candidate of the company, CaPre is developed for the treatment of severe hypertriglyceridemia, which is a condition characterized by abnormally high levels of triglycerides in the bloodstream. The company operates through the single segment being Development and commercialization of prescription drugs.

Contact Information

Website: www.acastipharma.com
Email: ACST@crescendo-ir.com
Main Phone: +1 317 294-9474
Address: 545 Promenade du Centropolis
Address 2: Suite 100
State: QC
City / Town: Laval
Country: CAN
Postal Code: H7T 0A3

Issuer Information

Exchange: NSC
CEO: Janelle D'Alvise
Employees: 24
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.66 $ -0.0102 (-1.52%)
Last Price 0.66 Change $ -0.0102 Change % -1.52 Tick N/A
Bid 0.66 Bid Size 2,200.00 Ask 0.67 Ask Size 2,100.00
Open 0.68 High 0.70 Low 0.65 Prev Close 0.67
Last Trade Volume 455,272 52 Wk Hi 1.80 52 Wk Low 0.43
Market Cap 51.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 78,128,567.00 EPS (TTM) -1.21 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7 7 7 7
Low Target Price Estimate 2.4 2.4 2.4 2.4
Mean Target Price Estimate 4.7 4.7 4.7 4.7
Standard Deviation 3.25 3.25 3.25 3.25
Date of Most Recent Estimate 04/16/18 04/16/18 04/16/18 04/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1